(19)
(11) EP 3 000 883 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
28.02.2018 Bulletin 2018/09

(45) Mention of the grant of the patent:
10.01.2018 Bulletin 2018/02

(21) Application number: 15177553.3

(22) Date of filing: 10.11.2011
(51) International Patent Classification (IPC): 
C12N 15/10(2006.01)
C12P 19/34(2006.01)
 C12N 15/66(2006.01)

(54)

METHODS AND DEVICES FOR NUCLEIC ACIDS SYNTHESIS

VERFAHREN UND VORRICHTUNGEN FÜR NUKLEINSÄURESYNTHESE

PROCÉDÉS ET DISPOSITIFS POUR LA SYNTHÈSE D'ACIDES NUCLÉIQUES

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 12.11.2010 US 412937 P
30.11.2010 US 418095 P
23.03.2011 US 201161466814 P
01.07.2011 US 201161503722 P

(43) Date of publication of application:
30.03.2016 Bulletin 2016/13

(60) Divisional application:
17206538.5

(62) Application number of the earlier application in accordance with Art. 76 EPC:
11791120.6 / 2638157

(73) Proprietor: Gen9, Inc.
Boston MA 02210 (US)

(72) Inventors:
  • JACOBSON, Joseph
    Newton, MA 02459 (US)
  • KUNG, Li-yun, A
    Arlington, MA 02474 (US)
  • WILSON, Andrew Kirk
    Laguna Beach, CA 92651 (US)
  • RAMU, Senthil
    Boston, MA 02114 (US)
  • SCHINDLER, Daniel
    Newton, MA 02464 (US)
  • HUDSON, Mike
    Framingham, MA 01701 (US)

(74) Representative: Sutcliffe, Nicholas Robert et al
Mewburn Ellis LLP
City Tower 40 Basinghall Street London EC2V 5DE
City Tower 40 Basinghall Street London EC2V 5DE (GB)


(56) References cited: : 
WO-A2-2004/024886
WO-A2-2010/025310
 WO-A2-2005/059096
WO-A2-2011/085075
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).